8-azabicyclo[3.2.1]octyl-2-hydroxybenz amide compounds as mu opioid receptor antagonists

Details for Australian Patent Application No. 2008293974 (hide)

Owner Theravance, Inc.

Inventors Saito, Daisuke Roland; Long, Daniel D.; Church, Timothy J.; Van Dyke, Priscilla; Frieman, Bryan; Jiang, Lan

Agent Davies Collison Cave

Pub. Number AU-A-2008293974

PCT Pub. Number WO2009/029256

Priority 61/051,065 07.05.08 US; 60/966,364 27.08.07 US

Filing date 26 August 2008

Wipo publication date 5 March 2009

International Classifications

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/029256 Priority application(s): WO2009/029256

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008293976-Fiber optic cable control clips and enclosure assemblies and methods incorporating the same

2008293972-Optical spectroscopic device for the identification of cervical cancer